John Christodouleas
xristodouleas.bsky.social
John Christodouleas
@xristodouleas.bsky.social
Radiation Oncologist at PENN and Elekta Medical Affairs.
Many studies now track ADC changes in tumors across different disease sites, and one exciting emerging observation is that changes appear mainly within the first 1-2 weeks of treatment. Gives hope that ADC kinetics will be useful to optimize treatment!
April 27, 2025 at 2:20 PM
The framing is especially interesting when the paradigm is rapidly evolving. Most patients in MR cohort were treated with 3 fractions, a scheme for which there is no established IGRT standard.
April 27, 2025 at 2:19 PM
Study begs the question: is the burden of proof on the RO community to show that MR-guidance is superior to CT-guidance (because MR is more expensive than CT) or to show that CT-guidance is non-inferior to MR-guidance (since you can’t see the target on CT)?
April 27, 2025 at 2:19 PM
user-swndwmf.cld.bz/ESTRO-2025-A.... Improved LC in MR cohort even after adjusting for known confounders (1 yr LC 94.5% for MRL and 83.5% for CBCT-guided).
ESTRO 2025 - Abstract Book
Animated publication
user-swndwmf.cld.bz
April 27, 2025 at 2:19 PM
Notable as it's from North America, where RTT-led workflow adoption has been slower than in Europe. We need to figure this out globally and minimize obstacles to adapting plans to changing anatomy!
April 27, 2025 at 2:17 PM